26 November 2021 - Senate Democrats expect to defend key portions of their drug pricing agenda against a technical challenge by Republicans as soon as next week, potentially curtailing crucial parts of their social spending and tax package.

Democrats expect to go before the Senate parliamentarian, a nonpartisan official who oversees that chamber’s rules, during the first days in December to get guidance on whether many of the health policy items in their House-passed bill (H.R. 5376) qualify under budget reconciliation, two senior Democratic aides told Bloomberg Government. That process allows legislation to pass in the Senate with a simply majority vote on the condition that the bill’s provisions are primarily budget related.

Read Bloomberg Government article